Results 251 to 260 of about 3,934,990 (326)

Photoacoustic Microscopy for Multiscale Biological System Visualization and Clinical Translation

Advanced Science, Volume 13, Issue 9, 13 February 2026.
Photoacoustic microscopy (PAM) is a powerful biomedical imaging tool renowned for its non‐invasiveness and high resolution. This review synthesizes recent technological advances and highlights their broad applications from cellular and organ‐level to whole‐animal imaging.
Tingting Wang, Jiali Chen, Liming Nie, Honghui Li   +3 more
wiley   +1 more source

Biological Templates for Gold Nanocluster Assembly: Design and Biomedical Applications

Aggregate, Volume 7, Issue 2, February 2026.
The review discusses the fundamental properties of ultrasmall gold nanoclusters and their surface modification strategies for targeted biomedical use. It examines biologically guided assembly processes and their effects on optical behavior, particularly aggregation‐induced emission.
Zeineb Ayed, Abdallah Alhalabi, Didier Gasparutto, Xavier Le Guével   +3 more
wiley   +1 more source

Peptide and Drug‐Protected Gold Nanoclusters as Promising Biomaterials: Synthesis, Properties, and Applications

Aggregate, Volume 7, Issue 2, February 2026.
The integration of atomically precise gold nanoclusters with peptides or drugs represents a cutting‐edge class of nanomaterials in the biomedical field, owing to their unique physicochemical properties such as water solubility, excellent biocompatibility, low toxicity, and good renal clearance.
Rebeca Garcia Moura, M. Terêsa Machini, Rongchao Jin   +2 more
wiley   +1 more source

The Marriage of Metal Nanoclusters With Reticular Frameworks: Synthetic Strategies and Biomedical Applications

Aggregate, Volume 7, Issue 2, February 2026.
The integration of metal nanoclusters (MNCs) with reticular frameworks (RFs) has recently emerged as a powerful strategy to create composite materials with enhanced and synergistic functionalities. This review provides an overview of the synthetic strategies developed for constructing MNCs/RFs composites and their recent advances in biomedical ...
Wenfeng Liu, Qinyin Yin, Li‐Li Tan, Li Shang   +3 more
wiley   +1 more source

A Dual‐Acceptor Engineered Second Near‐Infrared Ionic Aggregation‐Induced Emission Luminogen for Mitochondria‐Disrupted Cancer Phototheranostics

Aggregate, Volume 7, Issue 2, February 2026.
A finely engineered ionic phototheranostic agent, DT‐BT‐BIn, with aggregation‐induced emission characteristics and enhanced phototherapeutic activity can achieve NIR‐II fluorescence and photothermal imaging‐guided precise and effective in vivo tumor ablation via cell apoptosis.
Yuanyuan You, Songling Lin, Chengwei Tang, Qiongwen Liang, Huachan Deng, Lu Li, Yuxun Ding, Jiayi Chen, Jiachun Chen, Dingyuan Yan, Dong Wang, Xiaohui Chen   +11 more
wiley   +1 more source

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, Volume 6, Issue 2, February 2026.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source

Beyond Treatment: The Strategy of Nonintervention in Choroidal Hemangioma. [PDF]

Clin Case Rep
Khan H, Faheem MSB, Fatima H, Asghar A, Khan AA, Zahid MR, Hassan ST, Shakkel I, Khan MI.   +8 more
europepmc   +1 more source

Engineering Ultrasound Contrast Agents for Targeted Therapeutics: A Theranostic Approach to Drug Delivery, Gene Therapy, and Immunomodulation

Advanced NanoBiomed Research, Volume 6, Issue 2, February 2026.
Ultrasound contrast agents, including microbubbles and nanobubbles, transform imaging and targeted therapy through precise engineering of size, shell composition, and surface properties. This review explores how these innovations enable tissue‐specific delivery, enhance therapeutic efficacy, and extend applications from vascular imaging to tumor ...
Ashkan Seza, Kimia Mozahheb Yousefi, Sara Minaeian   +2 more
wiley   +1 more source

Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer

BJUI Compass, Volume 7, Issue 2, February 2026.
Abstract Objectives To prospectively evaluate oncological control, pathological progression, and its predictors following focal low‐dose‐rate (LDR) brachytherapy for low‐intermediate risk prostate cancer (PCa). Patients and methods LIBERATE is a prospective, multi‐centre clinical registry of patients who have undergone focal LDR brachytherapy for low ...
Mohammadmehdi Adhami, Jeremy Cheng, Elliot Anderson, Lloyd Smyth, Cate Davey, Thang Nguyen, Richard O'Sullivan, Andrew Ryan, Nathan Lawrentschuk, Jeremy Grummet, Andrew See   +10 more
wiley   +1 more source

Effect of extending the oral administration period of 5‐aminolevulinic acid on diagnostic accuracy and treatment outcomes for non–muscle‐invasive bladder cancer

BJUI Compass, Volume 7, Issue 2, February 2026.
Abstract Objectives To evaluate the treatment outcomes of 5‐aminolevulinic acid hydrochloride (5‐ALA) photodynamic diagnosis (PDD)‐assisted transurethral resection of bladder tumour (TURBT) (ALA PDD‐TURBT, hereinafter referred to as ‘ALA‐PDD’) exceeding 4 h after ALA administration for non–muscle‐invasive bladder cancer (NMIBC).
Hideo Fukuhara, Ryu Shigehisa, Shinkuro Yamamoto, Satoshi Fukata, Kenta Saito, Yasuhiko Shibanaka, Keiji Inoue   +6 more
wiley   +1 more source